BR112018001737A2 - composição farmacêutica com micela polimérica - Google Patents

composição farmacêutica com micela polimérica

Info

Publication number
BR112018001737A2
BR112018001737A2 BR112018001737A BR112018001737A BR112018001737A2 BR 112018001737 A2 BR112018001737 A2 BR 112018001737A2 BR 112018001737 A BR112018001737 A BR 112018001737A BR 112018001737 A BR112018001737 A BR 112018001737A BR 112018001737 A2 BR112018001737 A2 BR 112018001737A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
polymeric micelle
micelle
polymeric
preparing
Prior art date
Application number
BR112018001737A
Other languages
English (en)
Inventor
Oh Kim Bong
Chan MIN Bum
Rim Kim Hye
Yeong KIM Ji
Jin Kyung Kyu
Hyo Seo Min
Woong Yi Yil
Jeong Yoon Yoo
Original Assignee
Samyang Biopharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Biopharmaceuticals filed Critical Samyang Biopharmaceuticals
Publication of BR112018001737A2 publication Critical patent/BR112018001737A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

são providos uma composição farmacêutica contendo um composto relacionado específico em uma quantidade dentro de um limite especificado e um método para preparar a mesma.
BR112018001737A 2015-07-28 2016-07-28 composição farmacêutica com micela polimérica BR112018001737A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20150106629 2015-07-28
PCT/KR2016/008270 WO2017018820A1 (en) 2015-07-28 2016-07-28 Pharmaceutical composition with improved storage stability and method for preparing the same

Publications (1)

Publication Number Publication Date
BR112018001737A2 true BR112018001737A2 (pt) 2018-09-11

Family

ID=57884713

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018001737A BR112018001737A2 (pt) 2015-07-28 2016-07-28 composição farmacêutica com micela polimérica

Country Status (13)

Country Link
EP (1) EP3328437A4 (pt)
JP (1) JP2018521105A (pt)
KR (1) KR101787453B1 (pt)
CN (1) CN107466231A (pt)
AU (1) AU2016299548A1 (pt)
BR (1) BR112018001737A2 (pt)
CA (1) CA2993928A1 (pt)
HK (1) HK1249441A1 (pt)
IL (1) IL257187A (pt)
MX (1) MX2018001223A (pt)
RU (1) RU2018107055A (pt)
WO (1) WO2017018820A1 (pt)
ZA (1) ZA201801187B (pt)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020507A (en) 1998-03-02 2000-02-01 Bristol-Myers Squibb Company Synthesis of paclitaxel from baccatin III by protection of the 7-hydroxyl of baccatin III using a strong base and an electrophile
JP4049588B2 (ja) * 2000-05-12 2008-02-20 サムヤン コーポレイション ブロック共重合体の相分離による高分子ミセルの製造方法
US7217770B2 (en) * 2000-05-17 2007-05-15 Samyang Corporation Stable polymeric micelle-type drug composition and method for the preparation thereof
ES2292827T3 (es) * 2001-10-18 2008-03-16 Samyang Corporation Composicion micelar polimerica con estabilidad mejorada.
WO2005037840A1 (en) 2003-10-16 2005-04-28 Mayne Pharma (Usa), Inc. Method for inverting the c2’ hydroxyl group of taxane esters
US9801818B2 (en) * 2007-12-31 2017-10-31 Samyang Biopharmaceuticals Corporation Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug
KR101024742B1 (ko) * 2007-12-31 2011-03-24 주식회사 삼양사 탁산 함유 양친성 블록 공중합체 미셀 조성물 및 그 제조방법
WO2009091150A2 (en) * 2007-12-31 2009-07-23 Samyang Corporation Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof
EP2201935B1 (en) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Polymeric micelle composition containing a poorly soluble drug and preparation method of the same

Also Published As

Publication number Publication date
IL257187A (en) 2018-03-29
CN107466231A (zh) 2017-12-12
HK1249441A1 (zh) 2018-11-02
AU2016299548A1 (en) 2018-02-22
EP3328437A4 (en) 2019-03-20
MX2018001223A (es) 2018-11-09
JP2018521105A (ja) 2018-08-02
EP3328437A1 (en) 2018-06-06
KR20170015200A (ko) 2017-02-08
ZA201801187B (en) 2018-12-19
CA2993928A1 (en) 2017-02-02
KR101787453B1 (ko) 2017-10-19
RU2018107055A3 (pt) 2019-08-28
WO2017018820A1 (en) 2017-02-02
RU2018107055A (ru) 2019-08-28

Similar Documents

Publication Publication Date Title
HK1252531A1 (zh) 用於藥物遞送的具有滲透增强劑的組合物
CL2016002772A1 (es) Composiciones de insulina de rápida acción
GEP20217239B (en) Pharmaceutical composition
BR112018006696A2 (pt) métodos e sistemas para obter óleo a partir de uma composição de vinhoto
EP3385302A4 (en) Polymeric composition
PE20181186A1 (es) Proceso de llenado en caliente con cierres hechos de composiciones de polietileno bimodal
EP3225662A4 (en) One-pack addition curable silicone composition, method for storing same, and method for curing same
BR112016014880A2 (pt) Composição farmacêutica incluindo palonosetron
BR112017024699A2 (pt) Composição de sal organometálico, método para preparar uma composição de sal organometálico e composição lubrificante
DK3821905T3 (da) Insulin indeholdende farmaceutiske sammensætninger
HUE046729T2 (hu) Mirabegront tartalmazó gyógyszerkészítmény
EP3275452A4 (en) Pharmaceutical composition containing silibinin
EP3199175A4 (en) Pharmaceutical composition for injection
SG11201912186SA (en) Composition for injection
MX2015008588A (es) Composiciones y metodos para la transfeccion de polinucleótidos.
EP3296285A4 (en) Ester-based compound, composition containing same, method for preparing same, and resin composition containing same
EP3252087A4 (en) Composition for forming easy-to-detach thin resin film, and easy-to-detach thin resin film
BR112018001725A2 (pt) composição farmacêutica com micela polimérica.
BR112019002729A2 (pt) composição farmacêutica sólida e processo para preparar uma composição farmacêutica sólida
BR112018001736A2 (pt) ?composição farmacêutica com micela polimérica?
BR112018067656A2 (pt) composições farmacêuticas anti-abuso
BR112018001719A2 (pt) composição farmacêutica com micela polimérica, e, método para preparação de uma composição farmacêutica com micela polimérica.
EP3369419A4 (en) Composition for treating diabetes
EP3332787A4 (en) Transdermally absorbable composition
EP3330378A4 (en) MODIFIED siRNA, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]